NCT01442935 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT01442935
Title	Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases
Recruitment	Completed
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	UNICANCER
Indications	colon adenocarcinoma rectum adenocarcinoma colorectal adenocarcinoma
Therapies	Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin Cetuximab + Fluorouracil + Irinotecan + Leucovorin Bevacizumab + Fluorouracil + Irinotecan + Leucovorin Cetuximab + Fluorouracil + Leucovorin + Oxaliplatin Bevacizumab + Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin Cetuximab + Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin
Age Groups:	adult
Covered Countries	FRA

Facility	Status	City	State	Zip	Country	Details
Centre Val d'Aurelle		Montpellier		34298	France	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT01442935Clinical Trial Detail